Upgrade to SI Premium - Free Trial

BioAtla (BCAB)

3.59 +0.10 (2.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/7/26 *Est.)

Latest Headlines

Form ARS BioAtla, Inc. For: Dec 31 June 3, 2026 4:10 PM - SEC Filing Form DEFA14A BioAtla, Inc. June 3, 2026 4:09 PM - SEC Filing Form DEF 14A BioAtla, Inc. For: Jun 03 June 3, 2026 4:07 PM - SEC Filing Context Therapeutics amends BioAtla license deal for CT-202 drug May 18, 2026 6:45 AM - StreetInsider Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 May 18, 2026 6:45 AM - Globe NewsWire Form 10-Q BioAtla, Inc. For: Mar 31 May 15, 2026 4:10 PM - SEC Filing Form 10-K/A BioAtla, Inc. For: Dec 31 April 29, 2026 4:07 PM - SEC Filing Form 8-K BioAtla, Inc. For: Apr 02 April 2, 2026 4:06 PM - SEC Filing BioAtla, Inc. (BCAB) Tops Q4 EPS by 6c March 31, 2026 5:14 PM - StreetInsider Form S-8 BioAtla, Inc. March 31, 2026 4:51 PM - SEC Filing Form 8-K BioAtla, Inc. For: Mar 31 March 31, 2026 4:07 PM - SEC Filing Form 10-K BioAtla, Inc. For: Dec 31 March 31, 2026 4:07 PM - SEC Filing BioAtla announces 50-for-1 share consolidation effective April 6 March 31, 2026 4:07 PM - StreetInsider BioAtla Announces Share Consolidation March 31, 2026 4:07 PM - Globe NewsWire BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights March 31, 2026 4:05 PM - Globe NewsWire Form 8-K BioAtla, Inc. For: Mar 17 March 23, 2026 4:04 PM - SEC Filing Form 424B2 BioAtla, Inc. March 20, 2026 4:05 PM - SEC Filing Form 424B2 BioAtla, Inc. March 13, 2026 4:06 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 10 Filed by: Sievers Eric March 12, 2026 4:10 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 11 Filed by: SHORT JAY M PHD March 12, 2026 4:10 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 10 Filed by: Vasquez Christian March 12, 2026 4:10 PM - SEC Filing Form 424B2 BioAtla, Inc. March 9, 2026 6:01 AM - SEC Filing Full Article List